Ignite Creation Date:
2025-12-24 @ 1:05 PM
Ignite Modification Date:
2025-12-28 @ 11:36 AM
Study NCT ID:
NCT02707861
Status:
COMPLETED
Last Update Posted:
2021-03-11
First Post:
2016-03-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
Sponsor:
TaiMed Biologics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03
Start Date Type:
None
Primary Completion Date:
2018-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-08
First Submit QC Date:
None
Study First Post Date:
2016-03-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-01-07
Results First Submit QC Date:
None
Results First Post Date:
2021-03-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-18
Last Update Post Date:
2021-03-11
Last Update Post Date Type:
ACTUAL